University of Cincinnati trial compares omega-3 supplements for elderly adults at risk for dementia
Grant and Award Announcement
In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.
Updates every hour. Last Updated: 25-Jul-2025 14:10 ET (25-Jul-2025 18:10 GMT/UTC)
A first-of-its-kind University of Cincinnati trial will compare brain accessibility of two types of omega-3 supplements in elderly adults at risk for dementia.
People from different ethnic backgrounds may report physical symptoms rather than purely cognitive difficulties, leading to delays in the diagnosis of dementia.
A new study led by Queen Mary University of London has found that the symptoms people describe to their GP before they receive a dementia diagnosis differ according to their ethnic background.
Very early exposure to even a very small dose of herpes simplex virus (HSV) in infant mice can lead to cognitive decline later in life, according to findings from a new Dartmouth-led study, in collaboration with Harvard Medical School and published in the journal PLoS Pathogens. This is significant because of emerging data in human studies showing an association between HSV and Alzheimer’s disease in humans.
Alzheimer’s disease (AD) — a neurodegenerative disorder — comes with a significant socioeconomic burden. Recent studies have found a strong association between AD and metabolic syndrome (MetS), a cluster of conditions that include diabetes, obesity, high blood pressure, and abnormal blood fat levels. In a recently published literature review article, researchers explore the link between AD and each individual component of MetS, analyzing the potential underlying mechanisms at cellular and molecular levels.